Researchers evaluate treatment guidelines for African Americans with asthma – News-Medical.net

Researchers evaluate treatment guidelines for African Americans with asthma
News-Medical.net
In a first-of-its-kind clinical trial, asthma researchers at University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow) will evaluate treatment guidelines for African American children and young adults with asthma. "Each year African

View full post on asthma – Google News

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma

Condition:   Asthma
Interventions:   Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX;   Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Indacaterol 27.5 mcg;   Drug: Indacaterol 37.5;   Drug: Indacaterol 55 mcg;   Drug: Indacaterol 75 mcg;   Drug: Indacaterol 150 mcg;   Drug: Placebo
Sponsors:   Novartis;   Novartis Pharmaceuticals
Not yet recruiting – verified October 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Condition:   Pulmonary Disease, Chronic Obstructive
Interventions:   Drug: Umeclidinium bromide/Vilanterol;   Drug: Placebo ACCUHALER/DISKUS;   Drug: Fluticasone propionate/Salmeterol;   Drug: Placebo NDPI
Sponsors:   GlaxoSmithKline;   GlaxoSmithKline
Not yet recruiting – verified April 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days